✦ LIBER ✦

Flexibly timed once-daily dosing with degludec: a new ultra-long-acting basal insulin

✍ Scribed by Josse, R. G.; Woo, V.

Book ID: 121261320
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 788 KB
Volume: 15
Category: Article
ISSN: 1462-8902
DOI: 10.1111/dom.12114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin degludec, an ultra-long-acting b

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

✍ Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Jo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 203 KB

Degludec, a new ultra-long-acting basal

Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: Advances in clinical research

✍ Muñoz Torres, Manuel 📂 Article 📅 2014 🏛 Elsevier ⚖ 499 KB

A Randomized, Controlled Study of Once-D

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 751 KB

Use of insulin degludec, a new basal ins

Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal–bolus therapy in type 1 and type 2 diabetes

✍ Kerlan, Véronique; Gouet, Didier; Marre, Michel; Renard, Éric 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 311 KB

The Efficacy and Safety of Insulin Deglu

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

✍ Meneghini, L.; Atkin, S. L.; Gough, S. C. L.; Raz, I.; Blonde, L.; Shestakova, M 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 842 KB

Steady-state pharmacokinetics and glucod

Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus

✍ Sinha, V. P.; Howey, D. C.; Choi, S. L.; Mace, K. F.; Heise, T. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 775 KB